LoginRegister
    Govt still mulling to bring medical devices under CDSCO: Minister tells parliamentGovt still mulling to bring medical devices under CDSCO: Minister tells parliament
    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditionsPfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions
    FIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in IndiaFIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in India
    Knowledge sharing from 2019 World Conference on Access to Medical Products to be utilized for larger public welfare: Dr Harsh VardhanKnowledge sharing from 2019 World Conference on Access to Medical Products to be utilized for larger...
    Suven Life Sciences Q2 revenue up 39pc to Rs 280 croreSuven Life Sciences Q2 revenue up 39pc to Rs 280 crore
    Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operationsPanacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical...
    OxyContin maker Purdue Pharma gets court approval for covering plaintiffs feesOxyContin maker Purdue Pharma gets court approval for covering plaintiffs fees
    USFDA pulls up Mylan for manufacturing violations at Andhra plantUSFDA pulls up Mylan for manufacturing violations at Andhra plant
    Novartis shifts Shanghais focus from research to early developmentNovartis shifts Shanghai's focus from research to early development
    USFDA lens slow down Indian pharma exports, says CII officialUSFDA lens slow down Indian pharma exports, says CII official
    NCLAT rejects Dhanuka Labs Rs 1146 crore bid for Orchid Pharma for being less than Liquidation ValueNCLAT rejects Dhanuka Labs Rs 1146 crore bid for Orchid Pharma for being less than Liquidation Value
    Pharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics ActPharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics Act
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X